Royalty Pharma Future Growth

Future criteria checks 3/6

Royalty Pharma is forecast to grow earnings and revenue by 11.4% and 6% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 23.7% in 3 years.

Key information

11.4%

Earnings growth rate

12.2%

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth rate6.0%
Future return on equity23.7%
Analyst coverage

Good

Last updated13 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:RPD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,0589333,0042,8895
12/31/20252,8399082,6982,6165
12/31/20242,6636342,5852,4675
6/30/20242,2386734012,669N/A
3/31/20242,2397991,0192,619N/A
12/31/20232,3551,1358722,988N/A
9/30/20232,3241841,4222,785N/A
6/30/20232,3612555222,750N/A
3/31/20232,3593323742,718N/A
12/31/20222,237434022,144N/A
9/30/20222,2475074012,064N/A
6/30/20222,2594663121,995N/A
3/31/20222,2786022631,952N/A
12/31/20212,289620-1742,018N/A
9/30/20212,286783-7322,093N/A
6/30/20212,239972-1592,132N/A
3/31/20212,195493-4962,090N/A
12/31/20202,122495-1482,035N/A
9/30/20202,0081,7451041,947N/A
6/30/20201,9341,8637931,858N/A
3/31/20201,8802,0521,0931,705N/A
12/31/20191,8142,349-541,667N/A
12/31/20181,7951,3781,3491,618N/A
12/31/20171,5981,210N/A1,418N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RPD's forecast earnings growth (11.4% per year) is above the savings rate (0.8%).

Earnings vs Market: RPD's earnings (11.4% per year) are forecast to grow slower than the German market (20% per year).

High Growth Earnings: RPD's earnings are forecast to grow, but not significantly.

Revenue vs Market: RPD's revenue (6% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: RPD's revenue (6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: RPD's Return on Equity is forecast to be high in 3 years time (23.7%)


Discover growth companies